Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | 3.19M | $34.0M | 9.10% | +279.8K | 2026-06-30 |
| AIGH Capital Management LLC | 2.49M | $26.0M | 7.10% | +504.5K | 2026-06-30 |
| Solas Capital Management, LLC | 1.89M | $20.0M | 5.39% | -592.8K | 2026-06-30 |
| BlackRock, Inc. | 1.73M | $18.0M | 4.93% | +358.9K | 2026-06-30 |
| AWM Investment Company, Inc. | 1.16M | $12.0M | 3.31% | +440.2K | 2026-06-30 |
| Vanguard Capital Management LLC | 839.3K | $9.0M | 2.40% | -57.8K | 2026-06-30 |
| Prospect Capital Advisors, LLC | 497.8K | $5.0M | 1.42% | -- | 2026-06-30 |
| State Street Corp | 426.0K | $4.0M | 1.22% | +66.9K | 2026-06-30 |
| Geode Capital Management, LLC | 402.6K | $4.0M | 1.15% | +30.8K | 2026-06-30 |
| Jane Street Group, LLC | 233.9K | $2.0M | 0.67% | +209.8K | 2026-06-30 |
